Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual Meeting
Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on…
Revolutionizing Prescription Management: Ironsail Pharma Launches Advanced Pharmacy Network Technology
New York, New York, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Ironsail Pharma…
Sonrai Accelerates Cancer Therapeutics Research with Advanced Analytics
BELFAST, Northern Ireland, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Sonrai Analytics (Sonrai),…
Greentank and Advanced Inhalation Rituals Partner on First-of-Its-Kind Wellness Inhalable Device
TORONTO, Oct. 30, 2024 /PRNewswire/ -- Greentank Technologies today announced it has entered…
